A person's age influences the risk of a significant number of medical conditions, such as osteoporosis, dementia, cardiovascular diseases, diabetes, etc. Over the past four decades, the world has witnessed a rapid population aging, and life expectancy has been improved remarkably. In 2017, the growing age-related disease burden exceeded 50% of the total disease burden globally, posing both substantial health and economic challenges to the government and society. Moreover, the number of patients with multiple health conditions (i.e. multimorbidity) grows substantially in recent years with population aging. Clusters of health conditions sharing similar pathological processes (e.g., cardiovascular disease and diabetes) may benefit from a single intervention. This creates barriers for the policymaker to fully understand the consequence of a single program/policy among the elderly population, calling for innovative ways for economic evaluation. The need for healthy longevity and prevention of age-related diseases requires decision-makers to allocate scarce healthcare resources in an efficient, equitable, and evidence-driven manner.
There are numerous ways that health economics research can contribute to improving the management of age-related diseases. Cost-of-illness studies are helpful to show the size of the problem in terms of healthcare spending. Quality of life studies evaluate the impact of disease to the patients. Moreover, they can be used to evaluate the disease burden through quality-adjusted life years. Health economic evaluation such as cost-benefit analysis, cost-effectiveness analysis and cost-utility analysis informs healthcare policy makers which interventions represent the best value for money. While economic evaluation mainly improves efficiency in health resource allocation, recent research also promotes equity considerations in economic evaluation using methods such as extended cost-effectiveness analysis. This Research Topic aims to collect studies using different health economics methodologies in the field of age-related diseases.
We welcome contributions on a range of health economics studies on but not limited to:
· Health economic evaluation of interventions for age-related diseases;
· Cost and economic burden of age-related diseases
· Measuring quality of life in patients with age-related diseases;
· Correlation between socioeconomic status and age-related diseases;
· Inequalities in age-related diseases;
· This Research Topic is open to article types including Original Research, Systematic Review, Perspective, Editorial and Study Protocol.
Abstract submission is optional.
A person's age influences the risk of a significant number of medical conditions, such as osteoporosis, dementia, cardiovascular diseases, diabetes, etc. Over the past four decades, the world has witnessed a rapid population aging, and life expectancy has been improved remarkably. In 2017, the growing age-related disease burden exceeded 50% of the total disease burden globally, posing both substantial health and economic challenges to the government and society. Moreover, the number of patients with multiple health conditions (i.e. multimorbidity) grows substantially in recent years with population aging. Clusters of health conditions sharing similar pathological processes (e.g., cardiovascular disease and diabetes) may benefit from a single intervention. This creates barriers for the policymaker to fully understand the consequence of a single program/policy among the elderly population, calling for innovative ways for economic evaluation. The need for healthy longevity and prevention of age-related diseases requires decision-makers to allocate scarce healthcare resources in an efficient, equitable, and evidence-driven manner.
There are numerous ways that health economics research can contribute to improving the management of age-related diseases. Cost-of-illness studies are helpful to show the size of the problem in terms of healthcare spending. Quality of life studies evaluate the impact of disease to the patients. Moreover, they can be used to evaluate the disease burden through quality-adjusted life years. Health economic evaluation such as cost-benefit analysis, cost-effectiveness analysis and cost-utility analysis informs healthcare policy makers which interventions represent the best value for money. While economic evaluation mainly improves efficiency in health resource allocation, recent research also promotes equity considerations in economic evaluation using methods such as extended cost-effectiveness analysis. This Research Topic aims to collect studies using different health economics methodologies in the field of age-related diseases.
We welcome contributions on a range of health economics studies on but not limited to:
· Health economic evaluation of interventions for age-related diseases;
· Cost and economic burden of age-related diseases
· Measuring quality of life in patients with age-related diseases;
· Correlation between socioeconomic status and age-related diseases;
· Inequalities in age-related diseases;
· This Research Topic is open to article types including Original Research, Systematic Review, Perspective, Editorial and Study Protocol.
Abstract submission is optional.